CIK 0001359931 · Non-accelerated filer<br>Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 204580525
- Phone
- 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-07 | Smith Cynthia Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-06-07 | Solomon Michael Edward Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-06-07 | SARGEN GREGORY Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-06-07 | Levy Richard S Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-06-07 | Huang Jane Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-06-07 | GARCEAU ROGER Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-06-07 | BESHAR LUKE M Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-05-31 | Opaleye Management Inc. 10% owner | Sale | −5,824 | $2.90 | $17K | 108,696 |
| 2024-05-30 | Opaleye Management Inc. 10% owner | Sale | −9,230 | $2.94 | $27K | 114,520 |
| 2024-05-22 | Opaleye Management Inc. 10% owner | Sale | −9,300 | $3.02 | $28K | 2,272,859 |
| 2024-05-22 | Opaleye Management Inc. 10% owner | Sale | −500 | $3.00 | $2K | 123,750 |
| 2024-05-21 | Opaleye Management Inc. 10% owner | Sale | −31,200 | $3.06 | $95K | 2,282,159 |
| 2024-05-21 | Opaleye Management Inc. 10% owner | Sale | −1,800 | $3.06 | $6K | 124,250 |
| 2024-05-17 | Opaleye Management Inc. 10% owner | Sale | −47,250 | $3.33 | $157K | 2,333,044 |
| 2024-05-17 | Opaleye Management Inc. 10% owner | Sale | −19,685 | $3.06 | $60K | 2,313,359 |
| 2024-05-17 | Opaleye Management Inc. 10% owner | Sale | −2,750 | $3.33 | $9K | 127,250 |
| 2024-05-17 | Opaleye Management Inc. 10% owner | Sale | −1,200 | $3.06 | $4K | 126,050 |
| 2024-05-10 | Opaleye Management Inc. 10% owner | Sale | −151,700 | $3.11 | $472K | 2,380,294 |
| 2024-05-09 | Opaleye Management Inc. 10% owner | Sale | −30,600 | $3.09 | $95K | 2,531,994 |
| 2024-01-19 | Bandari Jathin Chief Medical Officer | Grant or award | +23,000 | 59,583 |
Page 6 of 8 · 154 trades